Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-06-16 | New | $1,150,015 | $1,150,015 | Equity Only | 04 06c 4a5 | SEC link |
2025-06-13 | New | $1,150,015 | $1,150,015 | Other | 04 06c 4a5 | SEC link |
2025-06-13 | Amended | $6,632,847 | $5,482,832 | Other | 04 06c 4a5 | SEC link |
Name | Role |
---|---|
Nancy Briefs | Director, Executive |
John Brooks | Director |
Jeffrey Karp | Director |
Ali Tavakkoli | Director |